XTX Topco Ltd Buys Shares of 7,096 Corteva, Inc. (NYSE:CTVA)

XTX Topco Ltd purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 7,096 shares of the company's stock, valued at approximately $404,000.

Other large investors have also added to or reduced their stakes in the company. Oak Thistle LLC purchased a new stake in Corteva during the 4th quarter valued at about $1,514,000. Van ECK Associates Corp boosted its stake in shares of Corteva by 5.9% in the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after buying an additional 525,531 shares during the last quarter. Swedbank AB boosted its stake in shares of Corteva by 51.9% in the fourth quarter. Swedbank AB now owns 695,641 shares of the company's stock worth $39,624,000 after buying an additional 237,764 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Corteva by 755.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock worth $31,486,000 after buying an additional 488,181 shares during the last quarter. Finally, S.E.E.D. Planning Group LLC boosted its stake in shares of Corteva by 54.5% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company's stock worth $5,474,000 after buying an additional 33,886 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.

Insider Buying and Selling at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares of the company's stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.14% of the stock is currently owned by corporate insiders.

Corteva Price Performance

Shares of NYSE:CTVA traded up $0.19 during midday trading on Monday, hitting $61.66. The company had a trading volume of 2,319,487 shares, compared to its average volume of 3,321,450. The business's 50-day simple moving average is $60.67 and its 200-day simple moving average is $60.47. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93. The stock has a market cap of $42.11 billion, a price-to-earnings ratio of 47.80, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, research analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on CTVA shares. Royal Bank of Canada upped their target price on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. UBS Group lowered their target price on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Oppenheimer increased their price target on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a research report on Friday, February 7th. Barclays increased their price target on Corteva from $62.00 to $64.00 and gave the stock an "equal weight" rating in a research report on Tuesday, January 21st. Finally, Argus upgraded Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target on the stock in a research report on Monday, March 31st. One analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $68.13.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.